The Effect of Intraprostatic Chronic Inflammation on Benign Prostatic Hyperplasia Treatment
권영기, 최미선, 서경원, 박철희, 장혁수, 김병훈, 김천일,
소속 상세정보
권영기 ( Kwon Young-Kee )
계명대학교 의과대학 비뇨기과학교실
최미선 ( Choe Mi-Sun )
계명대학교 의과대학 병리학교실
서경원 ( Seo Kyung-Won )
계명대학교 의과대학 비뇨기과학교실
박철희 ( Park Chol-Hee )
계명대학교 의과대학 비뇨기과학교실
장혁수 ( Chang Hyuk-Soo )
계명대학교 의과대학 비뇨기과학교실
김병훈 ( Kim Byung-Hoon )
계명대학교 의과대학 비뇨기과학교실
김천일 ( Kim Chun-Il )
계명대학교 의과대학 비뇨기과학교실
KMID : 0358320100510040266
Abstract
Purpose: Asymptomatic chronic inflammation of the prostate is a common finding in benign prostatic hyperplasia (BPH). We investigated how the chronic inflammation affects medical treatment for BPH.
Materials and Methods: One pathologist reviewed the chronic inflammation of 82 BPH patients who underwent transrectal ultrasonography (TRUS)-guided needle biopsy. The extent of chronic inflammation was classified into 4 grades, categorized into two groups: the low-grade group and the high-grade group. We compared total, voiding, and storage International Prostate Symptom Score (IPSS) and quality of life (QoL) between the groups at baseline and 1, 3, 6, and 12 months after medical treatment for BPH.
Results: There were no significant differences in total IPSS or QoL between the groups during the follow-up period. The low-grade group showed continuous improvement of storage symptoms until 12 months; however, the high-grade group showed improvement until 3 months. Maximal improvements of QoL were observed at 6 months in the high-grade group and at 3 months in the low-grade group. There was no episode of surgery in the low-grade group, but four patients in the high-grade group (9.1%) underwent surgical treatment due to acute urinary retention or insufficient therapeutic response.
Conclusions: Although there was no statistical significance, improvements in IPSS were higher and lasted longer in the low-grade group. We might suggest medical treatment for intraprostatic chronic inflammation in BPH patients.
키워드
Diagnosis;Inflammation;Prostatic hyperplasia
원문 및 링크아웃 정보
등재저널 정보